phenacetin and Breast Neoplasms studies

phenacetin and Breast Neoplasms

phenacetin has been researched along with Breast Neoplasms in 1 studies

Saridon: contains phenacetin, caffeine, propyphenazone & pyrithyldione

Breast Neoplasms: Tumors or cancer of the human BREAST.

Research Excerpts

Excerpt	Relevance	Reference
"Acquired resistance to fulvestrant and palbociclib is a new challenge to treatment of estrogen receptor positive (ER+) breast cancer."	7.96	Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib. ( Dubrovskyi, O; Dye, K; Gutgesell, LM; Huang, F; Li, Y; Ratia, K; Shen, Z; Thatcher, GRJ; Tonetti, DA; Xiong, R; Zhao, H; Zhao, J, 2020)
"Acquired resistance to fulvestrant and palbociclib is a new challenge to treatment of estrogen receptor positive (ER+) breast cancer."	3.96	Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib. ( Dubrovskyi, O; Dye, K; Gutgesell, LM; Huang, F; Li, Y; Ratia, K; Shen, Z; Thatcher, GRJ; Tonetti, DA; Xiong, R; Zhao, H; Zhao, J, 2020)

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Timeframe

Studies, this research(%)

All Research%

pre-1990

0 (0.00)

18.7374

1990's

0 (0.00)

18.2507

2000's

0 (0.00)

29.6817

2010's

0 (0.00)

24.3611

2020's

1 (100.00)

2.80

Authors

Authors	Studies
Li, Y	1
Zhao, J	1
Gutgesell, LM	1
Shen, Z	1
Ratia, K	1
Dye, K	1
Dubrovskyi, O	1
Zhao, H	1
Huang, F	1
Tonetti, DA	1
Thatcher, GRJ	1
Xiong, R	1

Studies

Li, Y

Zhao, J

Gutgesell, LM

Shen, Z

Ratia, K

Dye, K

Dubrovskyi, O

Zhao, H

Huang, F

Tonetti, DA

Thatcher, GRJ

Xiong, R

Other Studies

1 other study available for phenacetin and Breast Neoplasms

Article	Year
Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib. Journal of medicinal chemistry, 2020, 07-09, Volume: 63, Issue:13 Topics: Animals; Breast Neoplasms; Drug Resistance, Neoplasm; Fulvestrant; Humans; MCF-7 Cells; Mice; Models	2020

Article

Year

Novel Pyrrolopyridone Bromodomain and Extra-Terminal Motif (BET) Inhibitors Effective in Endocrine-Resistant ER+ Breast Cancer with Acquired Resistance to Fulvestrant and Palbociclib.

Journal of medicinal chemistry, 2020, 07-09, Volume: 63, Issue:13

Topics: Animals; Breast Neoplasms; Drug Resistance, Neoplasm; Fulvestrant; Humans; MCF-7 Cells; Mice; Models

2020